Pictet Asset Management (Switzerland)’s Biogen BIIB Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$356M	Buy	1,249,054 +140,688	+13%	+$41.9M	0.42%	60
2023 Q1	$308M	Buy	1,108,366 +398,460	+56%	+$110M	0.39%	64
2022 Q4	$197M	Buy	709,906 +15,681	+2%	+$4.43M	0.28%	105
2022 Q3	$185M	Buy	694,225 +183,164	+36%	+$38.9M	0.28%	110
2022 Q2	$104M	Sell	511,061 -27,759	-5%	-$5.67M	0.14%	191
2022 Q1	$113M	Buy	538,820 +35,494	+7%	+$7.72M	0.13%	202
2021 Q4	$121M	Sell	503,326 -173,436	-26%	-$44.6M	0.12%	205
2021 Q3	$192M	Buy	+676,762	New	+$222M	0.21%	138

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s BIIB Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Biogen (BIIB) stake by 13% in Q2 2023, buying an estimated $41.9M and bringing the position to 1,249,054 shares worth $356M. The position accounts for 0.42% of the portfolio, ranked #60.

Pictet Asset Management (Switzerland) first reported a position in BIIB in Q3 2021 and has held it in 8 quarters since. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

Pictet Asset Management (Switzerland) held 1,249,054 shares of Biogen worth $356M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 140,688 Biogen shares in Q2 2023, an estimated $41.9M.
Biogen made up 0.42% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #60 holding.
Pictet Asset Management (Switzerland) first reported a position in Biogen in Q3 2021 and has held it in 8 quarters since.
1,009 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.